Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
AstraZeneca
Biotech
AstraZeneca, Daiichi pull lung cancer BLA for Enhertu follow-up
After considering feedback from the FDA, the companies have voluntarily withdrawn the non-squamous NSCLC application and submitted a fresh BLA.
James Waldron
Nov 12, 2024 5:27am
AstraZeneca still 'playing to win' in obesity, execs say
Nov 4, 2024 11:49am
AZ licenses discarded rare disease drug to Monopar Therapeutics
Oct 24, 2024 2:54pm
With trial win, Merck looks to take on Sanofi, AZ in RSV
Oct 17, 2024 6:00pm
AstraZeneca pays CSPC $100M for preclinical heart disease drug
Oct 7, 2024 6:12am
Big pharma, biotech ‘won't necessarily be symbiotic’ in AI: S&P
Oct 2, 2024 11:23am
